Your browser doesn't support javascript.
loading
Unfolded Von Willebrand Factor Binds Protein S and Reduces Anticoagulant Activity.
Sim, Martha M S; Mollica, Molly Y; Alfar, Hammodah R; Hollifield, Melissa; Chung, Dominic W; Fu, Xiaoyun; Gandhapudi, Siva; Coenen, Daniëlle M; Prakhya, Kanakanagavalli Shravani; Mahmood, Dlovan F D; Banerjee, Meenakshi; Peng, Chi; Li, Xian; Thornton, Alice C; Porterfield, James Z; Sturgill, Jamie L; Sievert, Gail A; Barton-Baxter, Marietta; Zheng, Ze; Campbell, Kenneth S; Woodward, Jerold G; López, José A; Whiteheart, Sidney W; Garvy, Beth A; Wood, Jeremy P.
Affiliation
  • Sim MMS; Department of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
  • Mollica MY; Bloodworks Northwest Research Institute, WA, USA.
  • Alfar HR; Division of Hematology, School of Medicine, University of Washington, WA, USA.
  • Hollifield M; Department of Mechanical Engineering, University of Maryland, Baltimore County, MD, USA.
  • Chung DW; Department of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
  • Fu X; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
  • Gandhapudi S; Bloodworks Northwest Research Institute, WA, USA.
  • Coenen DM; Department of Biochemistry, University of Washington, WA, USA.
  • Prakhya KS; Bloodworks Northwest Research Institute, WA, USA.
  • Mahmood DFD; Division of Hematology, School of Medicine, University of Washington, WA, USA.
  • Banerjee M; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
  • Peng C; Department of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
  • Li X; Department of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
  • Thornton AC; Saha Cardiovascular Research Center, University of Kentucky, KY, USA.
  • Porterfield JZ; Department of Molecular and Cellular Biochemistry, University of Kentucky, KY, USA.
  • Sturgill JL; Department of Pharmacology and Nutritional Sciences, University of Kentucky, KY, USA.
  • Sievert GA; Saha Cardiovascular Research Center, University of Kentucky, KY, USA.
  • Barton-Baxter M; Division of Infectious Disease, University of Kentucky, KY, USA.
  • Zheng Z; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
  • Campbell KS; Division of Infectious Disease, University of Kentucky, KY, USA.
  • Woodward JG; Department of Microbiology, Immunology and Molecular Genetics, University of Kentucky, KY, USA.
  • López JA; Center for Clinical and Translational Science, University of Kentucky, KY, USA.
  • Whiteheart SW; Center for Clinical and Translational Science, University of Kentucky, KY, USA.
  • Garvy BA; Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Wood JP; Versiti Blood Research Institute, Milwaukee, WI, USA.
bioRxiv ; 2024 Feb 09.
Article in En | MEDLINE | ID: mdl-38370737
ABSTRACT
Protein S (PS), the critical plasma cofactor for the anticoagulants tissue factor (TF) pathway inhibitor (TFPI) and activated protein C (APC), circulates in two functionally distinct pools free (anticoagulant) or bound to complement component 4b-binding protein (C4BP) (anti-inflammatory). Acquired free PS deficiency is detected in several viral infections, but its cause is unclear. Here, we identified a shear-dependent interaction between PS and von Willebrand Factor (VWF) by mass spectrometry. Consistently, plasma PS and VWF comigrated in both native and agarose gel electrophoresis. The PS/VWF interaction was blocked by TFPI but not APC, suggesting an interaction with the C-terminal sex hormone binding globulin (SHBG) region of PS. Microfluidic systems, mimicking arterial laminar flow or disrupted turbulent flow, demonstrated that PS stably binds VWF as VWF unfolds under turbulent flow. PS/VWF complexes also localized to platelet thrombi under laminar arterial flow. In thrombin generation-based assays, shearing plasma decreased PS activity, an effect not seen in the absence of VWF. Finally, free PS deficiency in COVID-19 patients, measured using an antibody that binds near the C4BP binding site in SHBG, correlated with changes in VWF, but not C4BP, and with thrombin generation. Our data suggest that PS binds to a shear-exposed site on VWF, thus sequestering free PS and decreasing its anticoagulant activity, which would account for the increased thrombin generation potential. As many viral infections present with free PS deficiency, elevated circulating VWF, and increased vascular shear, we propose that the PS/VWF interaction reported here is a likely contributor to virus-associated thrombotic risk.
Key words